Skip to main content
OSTEOPORE LIMITED logo

OSTEOPORE LIMITED — Investor Relations & Filings

Ticker · OSX ISIN · AU0000053324 ASX Manufacturing
Open in API
Filings indexed 487 across all filing types
Latest filing 2024-11-20 Proxy Solicitation & In…
Country AU Australia
Listing ASX OSX

About OSTEOPORE LIMITED

https://osteopore.com

Osteopore Limited specializes in the design and manufacture of 3D-printed bioresorbable implants. The company utilizes a patented 3D printing process to create scaffolds from bioresorbable polymers, such as polycaprolactone, designed to mimic the natural microstructure of bone. These implants, including the Osteoplug, Osteomesh, and Osteostrip product lines, are applied in neurosurgical, craniofacial, and orthopedic procedures to facilitate bone healing and tissue regeneration. The scaffolds provide a temporary structural framework that supports the body's natural healing process before being gradually absorbed and replaced by the patient's own bone tissue. This technology aims to reduce long-term complications associated with permanent foreign implants by promoting natural tissue integration and restoration across various clinical applications.

Recent filings

Filing Released Lang Actions
Notice of General Meeting 54 pages 1.7MB
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice of General Meeting scheduled for 23 December 2024, including an Explanatory Memorandum and Proxy Form. It details resolutions to be voted on by shareholders, such as approval to issue convertible notes, director performance rights, a new employee securities incentive plan, strategic investment approval, and share grants. The document is primarily an announcement and information for shareholders to prepare for the meeting and vote, rather than a report of voting results or financial data. It does not contain financial statements or management discussion but is a formal meeting notice with explanatory details. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2024-11-20 English
Application for quotation of securities - OSX 7 pages 20.2KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an announcement from Osteopore Limited regarding the application for quotation of securities issued under an employee incentive scheme. It details the number and type of securities to be quoted, issue dates, and compliance with ASX Listing Rules. There are no financial statements, management discussion, or earnings data present. The document is a formal application for listing new securities on the exchange, which corresponds to announcements about share issues or capital changes. Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length is about 5994 characters, which is sufficient to contain substantive information about the share issue rather than just a brief notice or link, confirming it is not a mere announcement of a report publication or regulatory filing.
2024-11-18 English
Application for quotation of securities - OSX 7 pages 20.2KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an announcement from Osteopore Limited regarding the application for quotation of securities issued under an employee incentive scheme. It details the number and type of securities to be quoted, issue dates, and compliance with ASX Listing Rules. There is no financial performance data, management discussion, or report content. The document is a formal application for listing new securities on the exchange, which corresponds to announcements about share issues or capital changes. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is about 5995 characters, which is sufficient for a detailed announcement but not a full financial report.
2024-11-14 English
Osteopore inks DKSH deal to sell ortho products in Singapore 5 pages 395.2KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 6 November 2024 about Osteopore signing an exclusive multi-year contract sales and marketing agreement with DKSH for orthopaedic products. It details the terms of the agreement, background on both companies, and forward-looking statements. There are no financial statements, quarterly or annual results, nor any regulatory filings or certifications. The content focuses on a business partnership and commercial agreement rather than financial performance or governance changes. This fits the category of a Capital/Financing Update (CAP) as it relates to a significant commercial contract impacting the company's business operations and potential revenue streams. The document length is 8543 characters, sufficient for a detailed announcement but not a full financial report. Therefore, the most appropriate classification is CAP with high confidence.
2024-11-05 English
OSX partners scientists to drive regeneration innovation 5 pages 344.8KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 4 November 2024 about Osteopore Limited signing an investment agreement with renowned scientists to drive innovations in regenerative medicine. The content focuses on a strategic investment agreement, describing the terms of the investment, the parties involved, and the strategic rationale behind the investment. There are no financial statements, quarterly or annual results, nor is this a transcript of a call or a report publication notice. The document is a corporate announcement about a capital investment and strategic partnership, which fits the category of Capital/Financing Update (CAP). The length is over 10,000 characters, indicating it is a full announcement rather than a brief notice. Therefore, the appropriate classification is CAP with high confidence.
2024-11-03 English
Application for quotation of securities - OSX 6 pages 18.2KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is a standard ASX (Australian Securities Exchange) form used for the application for quotation of securities. It details the issuance and quotation of new securities resulting from options being exercised or convertible securities being converted. The document includes specifics such as the number of securities, issue date, issue price, and the resulting issued capital. It is not a financial report, earnings release, or management discussion, but rather an official announcement related to capital changes and securities quotation. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is the announcement itself, not just a brief notice or a report publication announcement.
2024-10-31 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.